Clinical Trial Update: Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT [NA]

View source ↗

Summary

A completed clinical trial evaluating Parafilm to prevent CLABSI in pediatric patients undergoing bone marrow transplant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Marrow Transplant
• Central Line-associated Bloodstream Infections

Drugs mentioned

• Parafilm

Snippet

Sponsor: Emory University | Conditions: Central Line Associated Bloodstream Infections (CLABSI), Bone Marrow Transplant | NA | Status: COMPLETED | Results posted: 2019-06-25